6
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Lack of a Serologic Response to an E1B Protein of Adenovirus 12 in Coeliac Disease

, , , , &
Pages 282-286 | Received 17 Jul 1988, Accepted 15 Nov 1988, Published online: 08 Jul 2009

References

  • Howdle P D, Losowsky M S. Coeliac disease. Gut defences in clinical practice, M S Losowsky, R V Heatley. Churchill Livingstone, Edinburgh 1986; 243–254
  • Corazza G R, Tabacchi P, Frisoni M, Prati C, Gas-Barrini G. DR and non-DR Ia allotypes are associated with susceptibilitv to coeliac disease. Gut 1985; 26: 1210–1213
  • Kagnoff M F, Austin R K, Hubert J J, Bernardin J E. Kaiarda DD'. Possible role for a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 1984; 160: 1544–1547
  • Karagiannis J A, Priddle J D, Jewell D P. Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12. Lancet 1987; 1: 884–886
  • Fry H M, Grayston J T. Adenoviruses. Virus infections of humans. Epidemiology and control, A S Evans. Plenum, New York 1984; 67–84
  • Kagnoff M F, Paterson Y J, Kumar P J, Kasarda D D, Carbone F R, Unsworth D J, Austin R K. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987; 28: 995–1001
  • Tooze J. Molecular biology of tumour viruses. DNA tumour viruses. 2nd ed. Cold Spring Harbor Laboratory, New York 1981; 547–575
  • Sawada Y, Fohring B, Shenk T E, Raska K. Tumo-rigenicity of Adenovirus-transformed cells: region EIA of adenovirus 12 confers resistance to natural killer cells. Virology 1985; 147: 41–21
  • Blair Zajdel M E, Barker M D, Dixon S C, Blair G E. The use of monoclonal antibodies to study the proteins specified by the transforming region of human adenoviruses. Biochem J 1985; 225: 649–655
  • Laskey R A. The use of intensifying screens, or organic scintillators, for visualizing radioactive molecules resolved by gel electrophoresis. Meth Enzymol 1980; 65: 363–371
  • Wood G M, Trejdosiewicz L K, Losowsky M S. ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods 1987; 97: 269–274

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.